☆ 4.6 Article

Novel diagnostic potential of miR-1 in patients with acute heart failure

PLOS ONE (2022)

Related references

Note: Only part of the references are listed.

Review Medicine, General & Internal

Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity?

Paolo Severino et al.

Summary: Heart failure is a multisystemic disease that requires evaluation and treatment based on key parameters such as left ventricular ejection fraction (LVEF). The definition and therapy of HF need to be revised to move away from the old simplistic perspective.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Acute Heart Failure in the 2021 ESC Heart Failure Guidelines: a scientific statement from the Association for Acute CardioVascular Care (ACVC) of the European Society of Cardiology

Josep Masip et al.

Summary: The current ESC Heart Failure Guidelines are comprehensive but lack detailed content and high-quality evidence for acute heart failure management.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Heart failure with mid-range or mildly reduced ejection fraction

Gianluigi Savarese et al.

Summary: HFmrEF, a subtype of heart failure, accounts for 25% of patients with heart failure, and has been relatively less explored compared to HFrEF and HFpEF. Patients with HFmrEF have milder symptoms and lower risk of cardiovascular events compared to those with HFrEF, but similar or greater risk of non-cardiovascular adverse events. Studies suggest that drugs effective in HFrEF patients may also be effective in HFmrEF patients.

NATURE REVIEWS CARDIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta-regression in the past four decades

Antoine Kimmoun et al.

Summary: This study analyzed AHF studies with more than 100 patients from 1980 to 2017 and found a declining trend in 30-day all-cause death rates, although mortality and readmission rates remained high. The increase in the use of oral neurohormonal antagonists may be associated with improved survival after AHF episodes.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection

Review Medicine, General & Internal

Prognostic value of microRNAs in heart failure A meta-analysis

Jie Yang et al.

Summary: The meta-analysis indicates that the expression levels of circulating miRNAs are associated with overall survival in heart failure patients, with certain miRNAs serving as strong prognostic biomarkers. Low expression levels of specific miRNAs could potentially lead to worse patient outcomes.

MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

The Role of microRNAs in Heart Failure: A Systematic Review

Ana Peterlin et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

Add to Collection

Review Medicine, Research & Experimental

Role of MicroRNAs in Diagnosis, Prognosis, and Treatment of Acute Heart Failure: Ambassadors from Intracellular Zone

Seyyed-Reza Sadat-Ebrahimi et al.

GALEN MEDICAL JOURNAL (2020)

Add to Collection

Article Oncology

Identification of miRNAs correlating with stage and progression of colorectal cancer

Milad Asadi et al.

COLORECTAL CANCER (2019)

Add to Collection

Review Medicine, General & Internal

miRNAs as biomarkers for diagnosis of heart failure A systematic review and meta-analysis

Hualin Yan et al.

MEDICINE (2017)

Add to Collection

Article Oncology

Circulating miRNA-21 is a promising biomarker for heart failure

Jianghua Zhang et al.

MOLECULAR MEDICINE REPORTS (2017)

Add to Collection

Review Medicine, Research & Experimental

Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine

Chiranjib Chakraborty et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2017)

Add to Collection

Review Biochemistry & Molecular Biology

The role of microRNAs in heart failure

Hongjiang Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Add to Collection

Review Biochemistry & Molecular Biology

miRNA and cholesterol homeostasis

Tae-Il Jeon et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)

Add to Collection

Review Biotechnology & Applied Microbiology

Circular RNAs are miRNA sponges and can be used as a new class of biomarker

Franceli Rodrigues Kulcheski et al.

JOURNAL OF BIOTECHNOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Distribution of miRNA expression across human tissues

Nicole Ludwig et al.

NUCLEIC ACIDS RESEARCH (2016)

Add to Collection

Review Oncology

MicroRNA (miRNA) in cancer

Kaladhar B. Reddy

CANCER CELL INTERNATIONAL (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

MicroRNAs in cardiovascular disease: an introduction for clinicians

Simon P. R. Romaine et al.

HEART (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study

Huseyin Altug Cakmak et al.

JOURNAL OF CARDIOVASCULAR MEDICINE (2015)

Add to Collection

Article Multidisciplinary Sciences

Circulating microRNAs and Outcome in Patients with Acute Heart Failure

Marie-France Seronde et al.

PLOS ONE (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

MicroRNAs in Heart Failure Is the Picture Becoming Less miRky?

Yonathan F. Melman et al.

CIRCULATION-HEART FAILURE (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical use of novel biomarkers in heart failure: towards personalized medicine

Daniela Schmitter et al.

HEART FAILURE REVIEWS (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure

Brent A. Dickinson et al.

EUROPEAN JOURNAL OF HEART FAILURE (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients

Katrina L. Ellis et al.

EUROPEAN JOURNAL OF HEART FAILURE (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction

Christophe Bauters et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)

Add to Collection

Article Hematology

Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease

Dorothee Kaudewitz et al.

THROMBOSIS AND HAEMOSTASIS (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Serum levels of microRNAs in patients with heart failure

Yaron Goren et al.

EUROPEAN JOURNAL OF HEART FAILURE (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

MiR423-5p As a Circulating Biomarker for Heart Failure

Anke J. Tijsen et al.

CIRCULATION RESEARCH (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease

Maarten F. Corsten et al.

CIRCULATION-CARDIOVASCULAR GENETICS (2010)

Add to Collection

Article Medical Laboratory Technology

Impact of Increased Body Mass Index on Accuracy of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP for Diagnosis of Decompensated Heart Failure and Prediction of All-Cause Mortality

Robert H. Christenson et al.

CLINICAL CHEMISTRY (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.